Zobrazeno 1 - 2
of 2
pro vyhledávání: '"Filippo de Marinis"'
Autor:
Filippo de Marinis, Fiona H Blackhall, Martin Früh, Dirk De Ruysscher, Cecila Le Pechoux, Mary O’ Brien, Enriqueta Felip, Silvia Novello, Sara Ramella, Paul Martin Putora, Markus Glatzer, Rafal Dziadziuszko, L. Arés, José Belderbos, Fiona McDonald, Christoph Pöttgen, Esther G.C. Troost, Ursula Nestle, Benjamin Besse, Martin Reck, Federico Cappuzzo, Joachim Widder, Raffaele Califano, Paul Van Houtte, Françoise Mornex, Virginie Westeel, Pilar Garrido, Ben J. Slotman, Stéphanie Peeters, Corinne Faivre-Finn
Publikováno v:
Putora, P M, Glatzer, M, Belderbos, J, Besse, B, Blackhall, F, Califano, R, Cappuzzo, F, de Marinis, F, Dziadziuszko, R, Felip, E, Faivre-Finn, C, Früh, M, Garrido, P, le Pechoux, C, McDonald, F, Nestle, U, Novello, S, O‘Brien, M, Paz Ares, L, Peeters, S, Pöttgen, C, Ramella, S, Reck, M, Slotman, B, Troost, E G C, van Houtte, P, Westeel, V, Widder, J, Mornex, F & de Ruysscher, D 2019, ' Prophylactic cranial irradiation in stage IV small cell lung cancer: Selection of patients amongst European IASLC and ESTRO experts ', Radiotherapy and Oncology, vol. 133, pp. 163-166 . https://doi.org/10.1016/j.radonc.2018.12.014
Radiotherapy and Oncology, 133, 163-166. Elsevier Ireland Ltd
Radiotherapy and Oncology, 133, 163-166. Elsevier Ireland Ltd
Background: Due to conflicting results between major trials the role of prophylactic cranial irradiation (PCI) in stage IV small cell lung cancer (SCLC) is controversial.Methods: We obtained a list of 13 European experts from both the European Societ
Autor:
Francovito Piantedosi, Antonio Santo, Claudia Proto, Antonio Frassoldati, Angelo Delmonte, Filippo de Marinis, Libero Ciuffreda, Enrico Cortesi, Paolo Bidoli, Graziella Pinotti, Marco Bregni, Riccardo Samaritani, Federico Cappuzzo, Lucio Crinò, Alfonso Illiano, Paola Cravero, Elisa Minenza, Giuseppe Tonini, Diana Giannarelli, Gianmauro Numico, Stefano Tamberi, Maria Giuseppina Sarobba, Francesco Grossi, Marina Chiara Garassino, Giuseppe Bronte
Objectives Brain metastases are common among patients with non-squamous non-small-cell lung cancer (NSCLC) and result in a poor prognosis. Consequently, such patients are often excluded from clinical trials. In Italy an expanded access program (EAP)
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2794d1e913ffea6eef310029db4b7f07
http://hdl.handle.net/11573/1296150
http://hdl.handle.net/11573/1296150